[{"Assets_0_Q1_USD":224820000.0,"EarningsPerShareBasic_1_Q1_USD":1.5,"EarningsPerShareDiluted_1_Q1_USD":1.42,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12436000.0,"NetIncomeLoss_1_Q1_USD":22924000.0,"StockholdersEquity_0_Q1_USD":166827000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":15257892.0,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170508"}]